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Site-directed Mutations in the Tumor-associated Cytokine, Autotaxin, Eliminate
Nucleotide Phosphodiesterase, Lysophospholipase D, and Motogenic Activities
Eunjin Koh,1 Timothy Clair, Elisa C. Woodhouse, Elliott Schiffmann, Lance Liotta, and Mary Stracke
Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, Maryland 20892
ABSTRACT
The exo-enzyme autotaxin/NPP2 (ATX/NPP2) is a potent stimulator of
cell migration, invasion, metastasis, and angiogenesis. Recently, ATX/
NPP2 was found to possess lysophospholipase D (lyso-LPD) activity, gen-
erating the bioactive mediator lysophosphatidic acid from precursors. In
the present study, we used site-directed mutagenesis to delineate the active
domain of lysophospholipid catalytic activity and to examine potential
overlap with the nucleotide phosphodiesterase domain. We found four
amino acid residues obligatory for the phosphodiesterase, lyso-PLD, and
migration-stimulating activities of ATX/NPP2, suggesting that 5-nucleo-
tide phosphodiesterase (PDE) and lyso-PLD share a common reaction
mechanism and inviting design of enzymatic inhibitors as therapeutic
agents for neoplastic disease.
INTRODUCTION
ATX/NPP2,2 a Mr 125,000 glycoprotein, is a member of the ecto/
exo-NPP family of enzymes. Expression of this cytokine increases
tumorigenicity and metastatic potential in transformed cells (1) and
elicits an angiogenic response in Matrigel plug assays (2). Recently,
two separate groups (3, 4) have demonstrated that, in addition to its
PDE activity, ATX/NPP2 possesses lyso-PLD activity that can gen-
erate LPA from LPC. LPA, in turn, might mediate many of the
activities attributed to ATX/NPP2 itself, including motility stimula-
tion, invasiveness, and late-stage angiogenesis. A functionally similar
enzyme, PLD, which hydrolyzes phosphatidylcholine to produce
phosphatidic acid, has been cloned from many species and studied
extensively (reviewed in Refs. 5 and 6). Its active site consists of
duplicated HxKxxxxD sequences, commonly referred to as HKD
motifs (7, 8). In contrast to both PDE and PLD, the active site for
lyso-PLD, which might provide insight into the enzymatic mechanism
of its action, has not yet been described. In this report, we have used
published reports detailing the amino acid requirements of the NPP-
associated PDE reactive center (9) as well as the HKD motif required
for PLD activity (7) as our models for constructing eight separate
mutant ATX/NPP2s. We present evidence that all three of the PDE,
lyso-PLD, and motogenic actions of ATX/NPP2 require at least four
identical amino acids for activity.
MATERIALS AND METHODS
Reagents. LPC (18:1), LPA (18:1), N-ethyl-N-(2-hydroxy-3-sulfopropyl)-
m-toluidine (TOOS), 4-aminoantipyrene (4-AAP), horseradish peroxidase,
choline oxidase, p-nitrophenyl-TMP, 5-AMP, and CPT were from Sigma (St.
Louis, MO).
Cell Culture. A2058 (human melanoma) and COS-1 (green monkey kid-
ney) cell lines were maintained as described previously (10).
Construction of ATX/NPP2 Mutants and Preparation of Mutant Pro-
teins. Site-directed point mutations of ATX/NPP2 were made by overlap exten-
sion PCR methodology as described previously (11). ATX/NPP2 cDNA, derived
from MDA 435 cells, was cloned into pcDNA3.1 vector (pcDNA3.atx/npp2) and
used as a template. PCR was performed using the Platinum Pfx DNA polymerase
(Invitrogen Life Technologies, Inc., Carlsbad, CA) and oligonucleotides designed
for each mutant (Table 1). Each mutant plasmid was sequenced to confirm the
presence of the mutation and the fidelity of the PCR amplification. COS-1 cells
were transiently transfected with pcDNA3.atx/npp2 or with each mutant plasmid
using LipofectAMINE 2000 reagent (Invitrogen Life Technologies, Inc.) per
manufacturer’s protocol. A nonvector control was produced by adding appropriate
medium and identical treatments but no vector to COS-1 cells. Each medium was
partially purified with concanavalin A-agarose as described previously (12).
Immunoblot Analysis. After Tris-Glycine SDS-PAGE (8–16%), proteins
were transferred onto Invitrolon membranes (Invitrogen Life Technologies,
Inc.). Affinity-purified anti-ATX/NPP2 (13) polyclonal antibodies were used
as primary antibodies, and horseradish peroxidase-conjugated goat antirabbit
IgG (Pierce, Rockford, IL) was used as secondary antibodies, followed by
signal development using enhanced chemiluminescence (Amersham Life Sci-
ences). Quantification of each recombinant protein was assessed by densito-
metric scanning and image analysis (Personal Densitometer SI and Image-
Quant software; Molecular Dynamics).
PDE and Lyso-PLD Assays. Partially purified conditioned medium from
transfected COS cells was adjusted to equal ATX/NPP2 protein concentrations
based on the intensity of immunoblot signals. Twenty-l samples (100-l
reaction volume) were incubated in DMEM-BSA at 37°C in the presence of
0.5 mM of either p-nitrophenyl-TMP (for PDE assays) or LPC (for lyso-PLD
assays). DMEM-BSA was used to mimic the conditions of the motility assays.
For determination of PDE activity, reactions were stopped after 30 min by the
addition of 900 l of 0.1 N NaOH, and the nitrophenol product was detected
by reading the absorbance at 410 nm (A410 nm  64  nmol). To determine
lyso-PLD activity, released choline was detected by a modification of the
enzymatic photometric assay described previously (14, 15). A 900-l cocktail
containing 50 mM Tris-HCl (pH 8), 5 mM CaCl2, 0.3 mM N-ethyl-N-(2-
hydroxy-3-sulfopropyl)-m-toluidine (TOOS), 0.5 mM 4-aminoantipyrene (4-
AAP), 5.3 units/ml horseradish peroxidase, and 2 units/ml choline oxidase
were added to the 100-l reaction mixture and were incubated for 15 min at
37°C. Absorbance was read at 555 nm and converted to nmol of choline by
comparison with a choline standard curve.
Cell Motility Assays. A2058 cells were prepared and used for motility
assays as described previously in detail (16). Partially purified conditioned
medium from transfected COS cells was adjusted to equal ATX/NPP2 protein
concentrations based on the intensity of immunoblot signals. Migrated cells
were counted under light microscopy at 200 (medium power field).
RESULTS AND DISCUSSION
Expression of Wild-Type and Mutant ATX/NPP2 Protein in
COS-1 Cells. ATX/NPP2 possesses both PDE (12) and lyso-LPD
enzyme activities (3, 4). We have found that the amino acid residue
T210 is obligatory for both PDE and motogenic activities (10), sug-
gesting that an intact PDE-reactive center is necessary for motility
stimulation. On the basis of sequence similarity to the known structure
of alkaline phosphatase, Gijsbers et al. (9) found three histidines and
three aspartates in PC1/NPP1 that were required for PDE activity and
were proposed to coordinate the binding of two metal ions within the
reaction center. A functionally similar enzyme, PLD, has been shown
Received 12/23/02; accepted 3/5/03.
The costs of publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked advertisement in accordance with
18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom requests for reprints should be addressed, at Laboratory of Pathology,
National Cancer Institute, NIH, Building 10, Room 2A33, 9000 Rockville Pike, Bethesda,
MD 20892. Phone: (301) 496-1843; Fax: (301) 402-8911; E-mail: kohe@mail.nih.gov.
2 The abbreviations used are: ATX, autotaxin; ATX/NPP2, autotaxin-NPP2; CPT,
1,3-dimethyl-8-cyclopentylxanthine; DMEM-BSA, DMEM with 0.1% (w/v) BSA; LPA,
lysophosphatidic acid; LPC, lysophosphatidylcholine; NPP, nucleotide phosphodiesterase
and pyrophosphatase; PDE, 5-nucleotide phosphodiesterase; PLD, phospholipase D;
lyso-PLD, lysophospholipase D.
2042
Research. 
on July 20, 2014. © 2003 American Association for Cancercancerres.aacrjournals.org Downloaded from 
to require an intact HKD motif (HxKxxxxD) for its catalytic activity
(7, 8). Using these two known reactions as our model for selecting
appropriate amino acids, we introduced point mutations into ATX/
NPP2 cDNA using overlap extension PCR methodology as described
in “Materials and Methods.”
Because histidines are crucial to catalysis in both of our enzyme
models and many other phosphoreactive catalytic sites, most of the
introduced mutations involved changes in histidine residues, with the
exception being T210A. Three mutations were placed into the ATX/
NPP2 homologues of histidines proposed to coordinate the binding of
metal ions: H316Q, H360Q, and H475Q. Although ATX/NPP2 has no
canonical HKD, mutations were created in those histidines from the
two most similar sites: H587 (HxKxxxxE), mutated into H587Q, and
H453 (HxxRKxxD), mutated into H453Q. The final two mutations
were chosen because of their proximity to the PDE catalytic site to
create H243Q and H298Q. The locations of these eight mutations
relative to known domains in ATX/NPP2 are shown schematically in
Fig. 1A. The residues associated with PDE activity are shown in red,
others are shown in blue.
Plasmids containing wild-type or mutant ATX/NPP2 cDNA were
transiently transfected into COS-1 cells. After 48 h, each medium was
collected and partially purified, then verified and quantified via im-
munoblot as shown in Fig. 1B. A non-vector-transfected medium
served as a negative control and failed to reveal a protein band on
immunoblot, suggesting that COS1 cells secrete undetectable levels of
ATX/NPP2.
Effect of Point Mutations on PDE and lyso-PLD Enzymatic
Activities. Each mutant ATX/NPP2 was tested for PDE and lyso-PLD
activities, using well-established colorimetric assays: p-nitrophenyl-TMP
Table 1 Oligonucleotides used for PCR production of point mutations
Primera Sequencesb
T210A-s 5-gtgtacccaactaaggcctttcctaactta-3
T210A-as 5-taagttaggaaaggccttagttgggtacac-3
H243Q-s 5-gatgccacttttcagctgcgagggcga-3
H243Q-as 5-tcgccctcgcagctgaaaagtggcatc-3
H298Q-s 5-accctgccagatcaagagaggccttcg-3
H298Q-as 5-cgaaggcctctcttgatctggcagggt-3
H316Q-s 5-cctgatttctctggacaaaaatatggccct-3
H316Q-as 5-agggccatatttttgtccagagaaatcagg-3
H360Q-s 5-tttgtcggagaccagggaatggaagat-3
H360Q-as 5-atcttccattccctggtctccgacaaa-3
H453Q-s 5-gaacgcagatggcaagttgcaaggaaa-3
H453Q-as 5-tttccttgcaacttgccatctgcgttc-3
H475Q-s 5-ttccagggagaccaaggatttgataac-3
H475Q-as 5-gttatcaaatccttggtctccctggaa-3
H587Q-s 5-ctcaacaaacggcttcaaacaaaagggtct-3
H587Q-as 5-agacccttttgtttgaagccgtttgttgag-3
a
-s and -as refer to sense and antisense primers.
b Mutated sequences are underlined.
Fig. 1. Effect of point mutations introduced into
ATX/NPP2 on enzyme activities. A, schematic repre-
sentation of the known domains of ATX/NPP2 with
our introduced mutations shown. Red, point mutations
that have been associated with PDE activity; blue,
other point mutations. B, immunoblot analysis of the
expression of wild-type (wt) ATX/NPP2 and each
mutant ATX/NPP2 in transiently transfected COS-1
cells. Proteins were quantified by densitometric scan-
ning and image analysis. C, PDE (f) and lyso-PLD
(LPLD, o) activities were measured as described in
“Materials and Methods” by using the partially puri-
fied protein preparations shown in B. Non-vector-
transfected COS-1 medium (w/o vector) served as
negative control. The results shown are the mean of
duplicate experiments. Samples with results signifi-
cantly different from the measured activity of wild-
type ATX/NPP2 are marked as follows: , P 0.001;
#, P  0.01.
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hydrolysis for PDE (12) and choline release from LPC for lyso-PLD (3).
Wild-type ATX/NPP2 served as positive control, and partially purified
conditioned medium from non-vector-transfected COS-1 cells as nega-
tive control in these experiments. For both types of assays, results were
expressed as a percentage of wild-type activity.
As shown in Fig. 1C, mutant ATX/NPP2s that were altered in the
PDE-reactive center (T210A, H316Q, H360Q, and H475Q) possessed
significantly reduced PDE activity compared with wild-type ATX/
NPP2 (P  0.01 for H316Q and H475Q; P  0.001 for T210A and
H360Q). This was an expected finding because Gijsberg et al. (9) had
found that mutations in the homologous amino acids of PC-1/NPP1
resulted in similarly reduced activity. In novel findings, these same
four mutant ATX/NPP2s (T210A, H316Q, H360Q, and H475Q) also
had greatly diminished lyso-PLD activity compared with wild-type
ATX/NPP2 (P  0.001 for all). In fact, these activity-negative forms
of ATX/NPP2 were not significantly different from the nonvector
control for the activity of either enzyme, even at substrate concentra-
tions that were saturating for the activity-positive forms. This fact
precludes comparison of substrate concentration dependence. In con-
trast, those ATX/NPP2 mutant proteins that most closely corre-
sponded to the HKD motif (H587Q and H453Q) had PDE and
lyso-PLD activities that were not significantly different from those of
native autotaxin. Similarly, the ATX/NPP2 mutants chosen for their
proximity to the PDE-reactive site (H243Q and H298Q) also retained
the activities of both enzymes, which were not significantly different
from the activity of native ATX/NPP2.
We have shown that the hydrolysis of LPC by ATX/NPP2 has
structural requirements for threonine and histidine identical to those
for nucleotide hydrolysis. Despite the similarity of substrates, phos-
pholipids versus lysophospholipids, the PLD and lyso-PLD enzymes
seem to use different catalytic strategies for the hydrolysis of phos-
phodiester bonds. The precise correspondence between the effects of
four separate point mutations on both PDE and lyso-PLD activities
strongly indicates the presence of a common enzymatic site in ATX/
NPP2, suggesting that ATX/NPP2/lyso-LPD uses a common reaction
mechanism for the hydrolysis of nucleotides and lysophospholipids.
Effect of Point Mutations on the Migration Responses of A2058
Cells. To determine the effects of these same eight mutations on the
capacity of the resulting ATX/NPP2s to stimulate motility, each was
tested via a modified Boyden chamber assay for its capacity to induce
a migration response in A2058 responder cells. Wild-type ATX/NPP2
served as the positive control in these experiments. Conditioned
medium from non-vector-transfected COS-1 cells, as well as DMEM-
BSA alone, served as negative controls. The result of a representative
motility assay is shown in Fig. 2A. The same four mutant ATX/NPP2s
that lacked both PDE and lyso-PLD activity (T210A, H316Q, H360Q,
and H475Q) also failed to stimulate motility (P  0.001 compared
with wild-type ATX/NPP2). These enzyme-negative mutants were
essentially no different from the nonvector control. In contrast, the
mutations that had no significant effect on any enzymatic activity
(H243Q, H298Q, H453Q, and H587Q) induced a migration response
that was equivalent to that of native autotaxin.
Similar results were obtained when 500 nM LPC was added to each
ATX/NPP2 sample, incubated at 37°C for 5 h, and then heated to
inactivate ATX/NPP2 before the migration assay. Heating in this
manner eliminates ATX/NPP2-stimulated motility but has no effect
on LPA stimulation (data not shown). In these substrate experiments,
wild-type ATX/NPP2 served as a positive control for the enzyme
action of ATX/NPP2, and 500 nM LPA served as the product control.
Negative controls included non-vector-transfected COS-1 medium
and 500 nM LPC alone. As shown in Fig. 2B, incubation of LPC with
T210A, H316Q, H360Q, or H475Q failed to produce a heat-stable
product and did not result in motility stimulation (P  0.001 com-
pared with wild-type ATX/NPP2; no significant difference from non-
vector control). However, incubation of LPC with H243Q, H298Q,
H453Q, or H587Q resulted in a heat-stable product that stimulated
migration in a manner equivalent to incubation with native ATX/
NPP2.
For the first time, we have shown that the capacity of mutant
ATX/NPP2s to induce migration correlates directly with their capac-
ity to hydrolyze both nucleotides and lysophospholipids. These data
present a cogent argument that the enzyme reactive center of ATX/
NPP2 must be intact for the protein to produce a migration response,
strongly implying that this response results from its enzymatic
products.
Adenosine Receptor Does Not Mediate ATX/NPP2 Migration
Response. The correlation of both PDE and lyso-LPD activities with
the stimulation of a motile response raises the possibility that nucle-
otides might also be important to ATX/NPP2-stimulated motility.
Platelets have been shown to release both adenosine nucleotides and
LPC (17), providing a physiological mixture of alternative substrates.
Tokumura et al. (4) found that high concentrations (5–10 mM) of ATP
or p-nitrophenyl-TMP inhibited choline release from LPC, suggesting
the possibility of complex substrate interactions in the microenviron-
ment of the cell. In addition, extracellular nucleosides and nucleotides
are known to elicit numerous physiological responses by binding to
specific membrane receptors. In A2058 cells, both adenosine and
5-AMP elicit similar pertussis-toxin-sensitive migration responses,
mediated by the A1 subclass of the P1 purinoceptor family (18).
We, therefore, tested the effect of the A1-specific adenosine analogue
CPT on the migration response of A2058 cells to both native ATX/NPP2
and 5-AMP. The results are shown in Fig. 3. CPT completely blocked
Fig. 2. Migration response stimulated by wild-type and mutant ATX/NPP2s. Migration
responses of A2058 cells were measured in modified Boyden chambers. A, direct re-
sponses were measured by using partially purified cultured medium of COS-1 cells
transfected with wild-type or mutant ATX/NPP2 as chemoattractant. B, indirect responses
to a heat-stable product (produced by incubating 500 nM LPC with each of the above
samples at 37°C for 5 h and then heat-inactivating the samples at 95°C for 15 min) were
measured. LPA (500 nM) served as positive control; non-vector-transfected COS-1 me-
dium (w/o vector) and LPC (500 nM) served as negative controls. Migrated cells were
counted at 200 (medium power field) and were expressed as mean  SD.
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the 5-AMP response (P  0.001 for CPT treated versus untreated) but
had no significant effect on ATX/NPP2-stimulated migration, indicating
that the ATX/NPP2 response is independent of the adenosine A1 recep-
tor. Although ATX/NPP2 possesses 5-nucleotide PDE activity, the mi-
gration elicited by the product of this reaction, AMP, is independent of
the motogenic effect of ATX/NPP2.
ATX/NPP2 Acts as a Member of the NPP Family. Our data
indicate that ATX/NPP2/lyso-PLD behaves like a member of the NPP
family of ecto/exo-enzymes (19, 20), using a common reactive site to
extend its capacity to hydrolyze nucleotide phosphoester bonds to
those of lysophospholipids. Aoki et al. (17) have recently shown that
ATX/NPP2 also hydrolyzes other glycerophospholipids, including
lysophosphatidylserine, lysophosphatidylethanolamine, and lysophos-
phatidylinositol, into LPA. Furthermore, this intact PDE/lyso-PLD
reactive site is obligatory for the motogenic activity of ATX/NPP2.
Because the product of the PDE enzymatic activity, AMP, is not
necessary for autotaxin-stimulated motility, our data strongly imply
that the motogenic activity of ATX/NPP2 is mediated entirely by its
production of bioactive phospholipids. This is a striking example of a
highly potent cytokine exerting its effects by directly controlling the
synthesis of an equally potent biological agent, LPA. The emerging
importance of such a phenomenon has widespread implications for the
regulation of the cellular microenvironment and for novel therapeutic
approaches to a variety of diseases that might affect any facet of this
regulation.
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